(Q54208520)
Statements
Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate cystic fibrosis. (English)
E F McKone
D Mathews
D Kerr
J S Wanger
S P Millard
Cystic Fibrosis Therapeutics Development Network
28 August 2007
7
2
147-153